Cardan Capital Partners’s Pfizer PFE Stock Holding History

Cardan Capital Partners’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	$575K	Buy	13,361 +416	+3%	+$18.4K	0.06%	149
2021 Q2	$507K	Sell	12,945 -22	-0.2%	-$856	0.06%	160
2021 Q1	$470K	Hold	12,967	–	–	0.06%	151
2020 Q4	$477K	Buy	12,967 +1,566	+14%	+$57.4K	0.06%	146
2020 Q3	$397K	Buy	11,401 +1,193	+12%	+$41.8K	0.05%	159
2020 Q2	$317K	Buy	+10,208	New	+$347K	0.05%	175
2019 Q2	–	Sell	-6,313	Closed	-$254K	–	173
2019 Q1	$254K	Sell	6,313 -34	-0.5%	-$1.36K	0.04%	156
2018 Q4	$263K	Sell	6,347 -32	-0.5%	-$1.33K	0.05%	148
2018 Q3	$267K	Hold	6,379	–	–	0.04%	154
2018 Q2	$220K	Sell	6,379 -2,880	-31%	-$98.4K	0.04%	169
2018 Q1	$312K	Buy	+9,259	New	+$318K	0.05%	147

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Cardan Capital Partners's PFE Position: Q3 2021 in Review

Cardan Capital Partners increased its Pfizer (PFE) stake by 3.2% in Q3 2021, buying an estimated $18.4K and bringing the position to 13,361 shares worth $575K. The position accounts for 0.06% of the portfolio, ranked #149.

Cardan Capital Partners first reported a position in PFE in Q1 2018 and has held it in 11 quarters since. 2,803 funds tracked by Wall St. Rank hold PFE as of Q3 2021.

Cardan Capital Partners held 13,361 shares of Pfizer worth $575K as of Q3 2021.
Cardan Capital Partners bought 416 Pfizer shares in Q3 2021, an estimated $18.4K.
Pfizer made up 0.06% of Cardan Capital Partners's portfolio in Q3 2021, its #149 holding.
Cardan Capital Partners first reported a position in Pfizer in Q1 2018 and has held it in 11 quarters since.
2,803 funds tracked by Wall St. Rank held Pfizer as of Q3 2021.

Based on Cardan Capital Partners's 13F filing for Q3 2021, filed 25 Oct 2021.